CurveBeam and StraxCorp Close Merger

2022-10-20

IPO并购

HATFIELD, Pa., Oct. 20, 2022 /PRNewswire/ -- Medical imaging companies CurveBeam, LLC and StraxCorp, Ltd., announced today that on Oct. 12, 2022, they completed the previously announced merger. Under the new name CurveBeam AI, Ltd., the company expands CurveBeam's financially viable point-of-care imaging solutions into the bone health space, and springboards artificial intelligence (AI) driven applications for weight bearing CT (WBCT) imaging.

CurveBeam is the leader in weight bearing CT imaging and has a global installation base.

"CurveBeam AI will continue to lead innovation in weight bearing CT imaging while also forging new paths in improving patient care," said CurveBeam AI CEO Greg Brown.

StraxCorp specializes in providing AI and deep learning AI (DLAI) solutions for bone separation, segmentation, and microstructure analysis as a means to aid clinicians in assessing fracture risk.

The companies have been collaborating since 2017. CurveBeam AI will apply the same AI & DLAI solutions to automated orthopedic analyses that will be delivered via CurveBeam AI's Cloud Services.

"CurveBeam AI is placing priority on research and development of the advancements necessary to make our solutions the standard of care," said Arun Singh, COO, CTO (CT), and President (Americas & Europe).

CurveBeam AI's global operations headquarters for product development, quality & regulatory, manufacturing and operations including marketing, sales and customer care will remain in Hatfield PA, USA. CurveBeam AI's corporate office in Melbourne, VIC, Australia, will cover AI research & development, quality & regulatory (AI) corporate finance, and IP functions. CurveBeam AI, which has 51 employees, is an unlisted public company backed by several major venture funds and is targeting an Initial Public Offering in Q2 2023.

SOURCE CURVEBEAM AI

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构